Your browser doesn't support javascript.
loading
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment.
Cucchetti, Alessandro; Gramenzi, Annagiulia; Johnson, Philip; Giannini, Edoardo G; Tovoli, Francesco; Rapaccini, Gian Ludovico; Marra, Fabio; Cabibbo, Giuseppe; Caturelli, Eugenio; Gasbarrini, Antonio; Svegliati-Baroni, Gianluca; Sacco, Rodolfo; Zoli, Marco; Morisco, Filomena; Di Marco, Maria; Mega, Andrea; Foschi, Francesco G; Biasini, Elisabetta; Masotto, Alberto; Nardone, Gerardo; Raimondo, Giovanni; Azzaroli, Francesco; Vidili, Gianpaolo; Brunetto, Maurizia R; Farinati, Fabio; Trevisani, Franco.
Afiliación
  • Cucchetti A; Department of Medical and Surgical Sciences, University of Bologna, Italy; Morgagni-Pierantoni Hospital, Forlì, Italy. Electronic address: alessandro.cucchett2@unibo.it.
  • Gramenzi A; Department of Medical and Surgical Sciences, Semeiotica Medica Unit, University of Bologna, Italy. Electronic address: annagiulia.gramenzi@unibo.it.
  • Johnson P; Department of Molecular and Clinical Cancer Medicine, University of Liverpool, UK. Electronic address: philip.johnson@liverpool.ac.uk.
  • Giannini EG; Department of Internal Medicine, Gastroenterology Unit, IRCCS Policlinico San Martino, University of Genova, Italy. Electronic address: egiannini@unige.it.
  • Tovoli F; Internal Medicine Unit, S. Orsola-Malpighi Hospital, Bologna, Italy. Electronic address: francesco.tovoli2@unibo.it.
  • Rapaccini GL; Department of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Roma, Italy. Electronic address: gianludovico.rapaccini@policlinicogemelli.it.
  • Marra F; Department of Experimental and Clinical Medicine, University of Firenze, Italy. Electronic address: fabio.marra@unifi.it.
  • Cabibbo G; Department of Health Promotion, Mother & Child Care, Internal Medicine & Medical Specialties (PROMISE), Section of Gastroenterology and Hepatology, University of Palermo, Italy. Electronic address: giuseppe.cabibbo78@gmail.com.
  • Caturelli E; Gastroenterology Unit, Belcolle Hospital, Viterbo, Italy. Electronic address: ecaturelli@tiscalinet.it.
  • Gasbarrini A; Internal Medicine and Gastroenterology Unit, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, Roma, Italy. Electronic address: antonio.gasbarrini@policlinicogemelli.it.
  • Svegliati-Baroni G; Department of Gastroenterology, Polytechnic University of Marche, Ancona, Italy. Electronic address: g.svegliati@univpm.it.
  • Sacco R; Gastroenterology and Digestive Endoscopy, Foggia University Hospital, Foggia, Italy. Electronic address: saccorodolfo@hotmail.com.
  • Zoli M; Department of Medical and Surgical Sciences, Internal Medicine Unit, University of Bologna, Italy. Electronic address: marco.zoli@unibo.it.
  • Morisco F; Department of Medicine and Surgery, Gastroenterology Unit, University of Napoli "Federico II", Italy. Electronic address: filomena.morisco@unina.it.
  • Di Marco M; Medicine Unit, Bolognini Hospital, Seriate, Italy. Electronic address: marielladimarco@gmail.com.
  • Mega A; Gastroenterology Unit, Bolzano Regional Hospital, Bolzano, Italy. Electronic address: andrea.mega@sabes.it.
  • Foschi FG; Department of Internal Medicine, Ospedale per gli Infermi di Faenza, Italy. Electronic address: francesco.foschi@auslromagna.it.
  • Biasini E; Infectious Diseases and Hepatology Unit, Azienda Ospedaliero-Universitaria di Parma, Italy. Electronic address: ebiasini@ao.pr.it.
  • Masotto A; Gastroenterology Unit, Ospedale Sacro Cuore Don Calabria, Negrar, Italy. Electronic address: alberto.masotto@sacrocuore.it.
  • Nardone G; Department of Clinical Medicine and Surgery, Hepato-Gastroenterology Unit, University of Napoli "Federico II", Italy. Electronic address: nardone@unina.it.
  • Raimondo G; Department of Clinical and Experimental Medicine, Clinical and Molecular Hepatology Unit, University of Messina, Italy. Electronic address: raimondo@unime.it.
  • Azzaroli F; Department of Medical and Surgical Sciences, Gastroenterology Unit, University of Bologna, Italy. Electronic address: francesco.azzaroli@unibo.it.
  • Vidili G; Department of Medical, Surgical and Experimental Sciences, Clinica Medica Unit, University of Sassari, Italy. Electronic address: gianpaolovidili@uniss.it.
  • Brunetto MR; Department of Clinical and Experimental Medicine, Hepatology and Liver Physiopathology Laboratory and Internal Medicine, University of Pisa, Italy. Electronic address: brunetto@med-club.it.
  • Farinati F; Department of Surgery, Oncology and Gastroenterology, University of Padova, Italy. Electronic address: fabio.farinati@unipd.it.
  • Trevisani F; Department of Medical and Surgical Sciences, Semeiotica Medica Unit, University of Bologna, Italy. Electronic address: franco.trevisani@unibo.it.
Eur J Cancer ; 158: 133-143, 2021 Oct 16.
Article en En | MEDLINE | ID: mdl-34666215
ABSTRACT

AIM:

This study investigated how material deprivation in Italy influences the stage of hepatocellular carcinoma (HCC) at diagnosis and the chance of cure.

METHODS:

4114 patients from the Italian Liver Cancer database consecutively diagnosed with HCC between January 2008 and December 2018 were analysed about severe material deprivation (SMD) rate tertiles of the region of birth and region of managing hospitals, according to the European Statistics on Income and Living Conditions. The main outcomes were HCC diagnosis modalities (during or outside surveillance), treatment adoption and overall survival.

RESULTS:

In more deprived regions, HCC was more frequently diagnosed during surveillance, while the incidental diagnosis was prevalent in the least deprived. Tumour characteristics did not differ among regions. The proportion of patients undergoing potentially curative treatments progressively decreased as the SMD worsened. Consequently, overall survival was better in less deprived regions. Patients who moved from most deprived to less deprived regions increased their probability of receiving potentially curative treatments by 1.11 times (95% CI 1.03 to 1.19), decreasing their mortality likelihood (hazard ratio 0.78 95% CI 0.67 to 0.90).

CONCLUSIONS:

Socioeconomic status measured through SMD does not seem to influence HCC features at diagnosis but brings a negative effect on the chance of receiving potentially curative treatments. Patient mobility from the most deprived to the less deprived regions increased the access to curative therapies, with the ultimate result of improving survival.
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Eur J Cancer Año: 2021 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Eur J Cancer Año: 2021 Tipo del documento: Article